Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong… - Journal of the National …, 2019 - jnccn.org
Journal of the National Comprehensive Cancer Network, 2019•jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of
recurrent and advanced disease for clinicians who treat patients with prostate cancer. The
portions of the guidelines included herein focus on the roles of germline and somatic genetic
testing, risk stratification with nomograms and tumor multigene molecular testing, androgen
deprivation therapy, secondary hormonal therapy, chemotherapy, and immunotherapy in …
risk stratification and workup, treatment options for localized disease, and management of
recurrent and advanced disease for clinicians who treat patients with prostate cancer. The
portions of the guidelines included herein focus on the roles of germline and somatic genetic
testing, risk stratification with nomograms and tumor multigene molecular testing, androgen
deprivation therapy, secondary hormonal therapy, chemotherapy, and immunotherapy in …
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer. The portions of the guidelines included herein focus on the roles of germline and somatic genetic testing, risk stratification with nomograms and tumor multigene molecular testing, androgen deprivation therapy, secondary hormonal therapy, chemotherapy, and immunotherapy in patients with prostate cancer.
jnccn.org